| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.38 | 6e-08 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.23 | 4e-06 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-05 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.11 | 5e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.18 | 0.0002 |